Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances M Platt

Showing results (91-100 of 193) with videos related to

Pageof 20
Sort By:
Chemmedchem|June 5, 2019
Synthesis and Study of Multifunctional Cyclodextrin-Deferasirox HybridsJose Miguel Gascon, Valentina Oliveri, Andrew McGown, et al.
Glycoconjugate Journal|November 10, 2021
Glycosphingolipid metabolism and its role in ageing and Parkinson's diseaseKerri-Lee Wallom, María E Fernández-Suárez, David A Priestman, et al.
Frontiers in Neurology|October 2, 2019
Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in <i>Cln3</i> <sup>-/-</sup> MiceMarta A Tarczyluk-Wells, Christoph Salzlechner, Allison R Najafi, et al.
Human Molecular Genetics|January 11, 2020
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytesGiulia Massaro, Michael P Hughes, Sammie M Whaler, et al.
International Journal of Molecular Sciences|February 23, 2018
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid LipofuscinosisAleksandra Somogyi, Anton Petcherski, Benedikt Beckert, et al.
Annals of Neurology|October 27, 2004
NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycinMylvaganam Jeyakumar, David A Smith, Ian M Williams, et al.
Neurobiology of Disease|August 29, 2025
A pathogenic alpha synuclein variant exacerbates disease progression in a neuron-specific Gba-KO mouseHannah B D Duffy, Colleen Byrnes, Hongling Zhu, et al.
Scientific Reports|July 14, 2017
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral SclerosisAlexandre Henriques, Mylene Huebecker, Hélène Blasco, et al.
The Journal of Biological Chemistry|September 13, 2007
Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesisCharlotte M Walden, Roger Sandhoff, Chia-Chen Chuang, et al.
Nature Medicine|January 21, 2014
RIPK3 as a potential therapeutic target for Gaucher's diseaseEinat B Vitner, Ran Salomon, Tamar Farfel-Becker, et al.
Pageof 20

Showing results (91-100 of 193) with videos related to

Sort By:
Pageof 20
Chemmedchem|June 5, 2019
Synthesis and Study of Multifunctional Cyclodextrin-Deferasirox HybridsJose Miguel Gascon, Valentina Oliveri, Andrew McGown, et al.
Glycoconjugate Journal|November 10, 2021
Glycosphingolipid metabolism and its role in ageing and Parkinson's diseaseKerri-Lee Wallom, María E Fernández-Suárez, David A Priestman, et al.
Frontiers in Neurology|October 2, 2019
Combined Anti-inflammatory and Neuroprotective Treatments Have the Potential to Impact Disease Phenotypes in <i>Cln3</i> <sup>-/-</sup> MiceMarta A Tarczyluk-Wells, Christoph Salzlechner, Allison R Najafi, et al.
Human Molecular Genetics|January 11, 2020
Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytesGiulia Massaro, Michael P Hughes, Sammie M Whaler, et al.
International Journal of Molecular Sciences|February 23, 2018
Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid LipofuscinosisAleksandra Somogyi, Anton Petcherski, Benedikt Beckert, et al.
Annals of Neurology|October 27, 2004
NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycinMylvaganam Jeyakumar, David A Smith, Ian M Williams, et al.
Neurobiology of Disease|August 29, 2025
A pathogenic alpha synuclein variant exacerbates disease progression in a neuron-specific Gba-KO mouseHannah B D Duffy, Colleen Byrnes, Hongling Zhu, et al.
Scientific Reports|July 14, 2017
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral SclerosisAlexandre Henriques, Mylene Huebecker, Hélène Blasco, et al.
The Journal of Biological Chemistry|September 13, 2007
Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesisCharlotte M Walden, Roger Sandhoff, Chia-Chen Chuang, et al.
Nature Medicine|January 21, 2014
RIPK3 as a potential therapeutic target for Gaucher's diseaseEinat B Vitner, Ran Salomon, Tamar Farfel-Becker, et al.
Pageof 20